174 related articles for article (PubMed ID: 17356265)
21. Renal protection by a soy diet in obese Zucker rats is associated with restoration of nitric oxide generation.
Trujillo J; Ramírez V; Pérez J; Torre-Villalvazo I; Torres N; Tovar AR; Muñoz RM; Uribe N; Gamba G; Bobadilla NA
Am J Physiol Renal Physiol; 2005 Jan; 288(1):F108-16. PubMed ID: 15328066
[TBL] [Abstract][Full Text] [Related]
22. Renoprotective and blood pressure-lowering effect of dietary soy protein via protein kinase C beta II inhibition in a rat model of metabolic syndrome.
Palanisamy N; Viswanathan P; Ravichandran MK; Anuradha CV
Can J Physiol Pharmacol; 2010 Jan; 88(1):28-37. PubMed ID: 20130736
[TBL] [Abstract][Full Text] [Related]
23. Differentially abundant mRNAs in rat liver in response to diets containing soy protein isolate.
Iqbal MJ; Yaegashi S; Ahsan R; Lightfoot DA; Banz WJ
Physiol Genomics; 2002 Dec; 11(3):219-26. PubMed ID: 12388795
[TBL] [Abstract][Full Text] [Related]
24. A cooperative interaction between soy protein and its isoflavone-enriched fraction lowers hepatic lipids in male obese Zucker rats and reduces blood platelet sensitivity in male Sprague-Dawley rats.
Peluso MR; Winters TA; Shanahan MF; Banz WJ
J Nutr; 2000 Sep; 130(9):2333-42. PubMed ID: 10958832
[TBL] [Abstract][Full Text] [Related]
25. Effects of Soy-derived diets on plasma and liver lipids, glucose tolerance, and longevity in normal, long-lived and short-lived mice.
Bartke A; Peluso MR; Moretz N; Wright C; Bonkowski M; Winters TA; Shanahan MF; Kopchick JJ; Banz WJ
Horm Metab Res; 2004 Aug; 36(8):550-8. PubMed ID: 15326565
[TBL] [Abstract][Full Text] [Related]
26. Soy protein isolate modified metabolic phenotype and hepatic Wnt signaling in obese Zucker rats.
Cain J; Banz WJ; Butteiger D; Davis JE
Horm Metab Res; 2011 Oct; 43(11):774-81. PubMed ID: 22009372
[TBL] [Abstract][Full Text] [Related]
27. Metabolic implications of dietary trans-fatty acids.
Dorfman SE; Laurent D; Gounarides JS; Li X; Mullarkey TL; Rocheford EC; Sari-Sarraf F; Hirsch EA; Hughes TE; Commerford SR
Obesity (Silver Spring); 2009 Jun; 17(6):1200-7. PubMed ID: 19584878
[TBL] [Abstract][Full Text] [Related]
28. Reduced mammary tumor progression in a transgenic mouse model fed an isoflavone-poor soy protein concentrate.
Chiesa G; Rigamonti E; Lovati MR; Disconzi E; Soldati S; Sacco MG; Catò EM; Patton V; Scanziani E; Vezzoni P; Arnoldi A; Locati D; Sirtori CR
Mol Nutr Food Res; 2008 Oct; 52(10):1121-9. PubMed ID: 18655005
[TBL] [Abstract][Full Text] [Related]
29. Dietary soy isoflavones increase insulin secretion and prevent the development of diabetic cataracts in streptozotocin-induced diabetic rats.
Lu MP; Wang R; Song X; Chibbar R; Wang X; Wu L; Meng QH
Nutr Res; 2008 Jul; 28(7):464-71. PubMed ID: 19083447
[TBL] [Abstract][Full Text] [Related]
30. Short- and Long-Term Soy Diet Versus Casein Protects Liver Steatosis Independent of the Arginine Content.
Hakkak R; Zeng H; Dhakal IB; Korourian S
J Med Food; 2015 Nov; 18(11):1274-80. PubMed ID: 26186426
[TBL] [Abstract][Full Text] [Related]
31. [Effects of soy isoflavone on low-grade inflammation in obese rats].
Zhang HM; Chen SW; Zhang LS; Feng XF
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):336-9. PubMed ID: 16859118
[TBL] [Abstract][Full Text] [Related]
32. Soy induces phase II enzymes but does not inhibit dimethylbenz[a]anthracene-induced carcinogenesis in female rats.
Appelt LC; Reicks MM
J Nutr; 1999 Oct; 129(10):1820-6. PubMed ID: 10498753
[TBL] [Abstract][Full Text] [Related]
33. Prolonged decrease of adipocyte size after rosiglitazone treatment in high- and low-fat-fed rats.
Johnson JA; Trasino SE; Ferrante AW; Vasselli JR
Obesity (Silver Spring); 2007 Nov; 15(11):2653-63. PubMed ID: 18070756
[TBL] [Abstract][Full Text] [Related]
34. Altered testicular microsomal steroidogenic enzyme activities in rats with lifetime exposure to soy isoflavones.
McVey MJ; Cooke GM; Curran IH
J Steroid Biochem Mol Biol; 2004 Dec; 92(5):435-46. PubMed ID: 15698548
[TBL] [Abstract][Full Text] [Related]
35. Dietary soy isoflavone-aglycone lowers food intake in female rats with and without ovariectomy.
Kishida T; Mizushige T; Ohtsu Y; Ishikawa S; Nagamoto M; Izumi T; Obata A; Ebihara K
Obesity (Silver Spring); 2008 Feb; 16(2):290-7. PubMed ID: 18239635
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of a soy-based compared with a traditional low-calorie diet on weight loss and lipid levels in overweight adults.
Liao FH; Shieh MJ; Yang SC; Lin SH; Chien YW
Nutrition; 2007; 23(7-8):551-6. PubMed ID: 17574819
[TBL] [Abstract][Full Text] [Related]
37. Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial.
Ho SC; Chen YM; Ho SS; Woo JL
Menopause; 2007; 14(5):905-12. PubMed ID: 17413839
[TBL] [Abstract][Full Text] [Related]
38. Dietary soy protein and isoflavones: no effect on the reproductive tract and minimal positive effect on bone resorption in the intact female Fischer 344 rat.
Nakai M; Black M; Jeffery EH; Bahr JM
Food Chem Toxicol; 2005 Jun; 43(6):945-9. PubMed ID: 15811574
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular consequences of life-long exposure to dietary isoflavones in the rat.
Douglas G; Armitage JA; Taylor PD; Lawson JR; Mann GE; Poston L
J Physiol; 2006 Mar; 571(Pt 2):477-87. PubMed ID: 16410278
[TBL] [Abstract][Full Text] [Related]
40. Effects of soy protein hydrolysate on blood pressure and angiotensin-converting enzyme activity in rats with chronic renal failure.
Yang HY; Chen JR; Chang LS
Hypertens Res; 2008 May; 31(5):957-63. PubMed ID: 18712051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
